Literature DB >> 22970769

Anti-gal antibodies in α1,3-galactosyltransferase gene-knockout pigs.

Jason Fang1, Anneke Walters, Hidetaka Hara, Cassandra Long, Peter Yeh, David Ayares, David K C Cooper, John Bianchi.   

Abstract

Serum anti-galactose-α1,3-galactose (Gal) IgM and IgG antibody levels were measured by ELISA in α1,3-galactosyltransferase gene-knockout (GTKO) pigs (78 estimations in 47 pigs). A low level of anti-Gal IgM was present soon after birth, and rose to a peak at 4-6 m, which was maintained thereafter even in the oldest pigs tested (at >2 yr). Anti-Gal IgG was also present at birth, peaked at 3 m, and after 6 m steadily decreased until almost undetectable at 20 m. No differences in this pattern were seen between pigs of different gender. Total IgM followed a similar pattern as anti-Gal IgM, but total IgG did not decrease after 6m. The data provide useful baseline data for future experimental studies in GTKO pigs, e.g., relating to the antibody response to WT pig allografts.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22970769      PMCID: PMC3444635          DOI: 10.1111/j.1399-3089.2012.00710.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  28 in total

1.  Upregulation of CD59: potential mechanism of accommodation in a large animal model.

Authors:  Adam D Griesemer; Masayoshi Okumi; Akira Shimizu; Shannon Moran; Yoshinori Ishikawa; Justin Iorio; J Scott Arn; Kazuhiko Yamada
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

2.  alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.

Authors:  A D Thall; H S Murphy; J B Lowe
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

Review 3.  The pig as a model of developmental immunology.

Authors:  H J Rothkötter; E Sowa; R Pabst
Journal:  Hum Exp Toxicol       Date:  2002 Sep-Oct       Impact factor: 2.903

4.  Anti-GaL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation.

Authors:  O P Minanov; S Itescu; F A Neethling; A S Morgenthau; P Kwiatkowski; D K Cooper; R E Michler
Journal:  Transplantation       Date:  1997-01-27       Impact factor: 4.939

5.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs.

Authors:  Yifan Dai; Todd D Vaught; Jeremy Boone; Shu-Hung Chen; Carol J Phelps; Suyapa Ball; Jeff A Monahan; Peter M Jobst; Kenneth J McCreath; Ashley E Lamborn; Jamie L Cowell-Lucero; Kevin D Wells; Alan Colman; Irina A Polejaeva; David L Ayares
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

6.  Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies.

Authors:  Isabel M McMorrow; Leo Buhler; Sarah Treter; Francisca A Neethling; Ian P J Alwayn; Christopher A Comrack; Hiroshi Kitamura; Michel Awwad; Harout DerSimonian; David K C Cooper; David H Sachs; Christian LeGuern
Journal:  Xenotransplantation       Date:  2002-03       Impact factor: 3.907

7.  Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates.

Authors:  Katsuhito Teranishi; Rafael Manez; Michel Awwad; David K C Cooper
Journal:  Xenotransplantation       Date:  2002-03       Impact factor: 3.907

8.  Investigation of potential carbohydrate antigen targets for human and baboon antibodies.

Authors:  Peter Yeh; Mohamed Ezzelarab; Nicolai Bovin; Hidetaka Hara; Cassandra Long; Koji Tomiyama; Frank Sun; David Ayares; Michel Awwad; David K C Cooper
Journal:  Xenotransplantation       Date:  2010 May-Jun       Impact factor: 3.907

9.  Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants.

Authors:  Pleunie P M Rood; Hao-Chih Tai; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; Yih J Lin; Dirk J van der Windt; Jamie Busch; David Ayares; Jan N M Ijzermans; Roman F Wolf; Rizwan Manji; Leonard Bailey; David K C Cooper
Journal:  Transpl Int       Date:  2007-09-10       Impact factor: 3.782

10.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

View more
  15 in total

1.  Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood?

Authors:  Goutham Kumar; Vikas Satyananda; Jason Fang; Hao Zhou; Minoru Fujita; Burcin Ekser; Cassandra Long; Eefje Dons; Qing Sun; David Ayares; Hidetaka Hara; David K C Cooper
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

Review 2.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

Review 3.  Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.

Authors:  Uri Galili
Journal:  J Mol Evol       Date:  2014-10-15       Impact factor: 2.395

Review 4.  α-Gal Nanoparticles in Wound and Burn Healing Acceleration.

Authors:  Uri Galili
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-03-01       Impact factor: 4.730

5.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

Review 6.  Modifying the sugar icing on the transplantation cake.

Authors:  David K C Cooper
Journal:  Glycobiology       Date:  2016-03-01       Impact factor: 4.313

7.  Biomanufacturing of Axon-Based Tissue Engineered Nerve Grafts Using Porcine GalSafe Neurons.

Authors:  Kritika S Katiyar; Justin C Burrell; Franco A Laimo; Kevin D Browne; John R Bianchi; Anneke Walters; David L Ayares; Douglas H Smith; Zarina S Ali; Harry C Ledebur; D Kacy Cullen
Journal:  Tissue Eng Part A       Date:  2021-04-09       Impact factor: 4.080

Review 8.  Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.

Authors:  Uri Galili
Journal:  J Immunol Res       Date:  2015-04-01       Impact factor: 4.818

Review 9.  The current state of xenotransplantation.

Authors:  J Zeyland; D Lipiński; R Słomski
Journal:  J Appl Genet       Date:  2014-12-07       Impact factor: 3.240

Review 10.  Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).

Authors:  Guoli Huai; Ping Qi; Hongji Yang; Yi Wang
Journal:  Int J Mol Med       Date:  2015-10-30       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.